According to a report by the New Beijing News on October 11th, after eight months of extensive investigation, the Second Brigade of the Coastal Police Division of the Hainan Provincial Public Security Department successfully dismantled a new addictive drug network with the support of the Anti-Drug Division and the Public Security Bureau of Wenchang City. A total of 10 suspects were arrested in this network, along with the seizure of 214 "Uptop e-cigarettes", 636 grams of "Uptop e-cigarette liquid", 11 mobile phones related to the case, and cash amounting to 38,200 yuan. The financial transactions involved in the case have exceeded 2 million yuan.
According to a recent investigation, a report from the Fengjia Coast Police Station in Wenchang City revealed that a certain product called "Upper e-cigarette" is being sold on the market. The report states that this product has the potential to cause symptoms such as dizziness, nausea, mental confusion, excitement, and tingling sensation on the scalp. It is also commonly referred to as the "Flying e-cigarette".
After conducting an investigation, the police have discovered a drug trafficking gang led by a certain Zhao that has been purchasing e-cigarettes and e-cigarette liquids from outside the province and selling them in the city of Wenchang. The quantity of sales has been enormous, involving a large number of individuals, and causing serious negative impacts on society. Upon learning about this, the Second Division of the Coast Police Headquarters immediately established a task force to conduct a thorough investigation. Through continuous investigations in Haikou, Wenchang, as well as Xuwen and Huazhou in Guangdong, the complete organizational structure of this drug trafficking network has been uncovered.
In September of this year, a special task force initiated an operation that successfully dismantled a cross-provincial drug trafficking channel from Guangdong Province to Hainan Province. It is worth noting that these e-cigarettes contain synthetic cannabinoids or ethyl methylphenidate, which can cause symptoms such as dizziness, nausea, and mental confusion with long-term use. Overuse can even lead to shock, asphyxiation, or sudden death.
Starting from July 1, 2021, China officially includes synthetic cannabinoids as a controlled substance. On September 6, 2023, the National Medical Products Administration, Ministry of Public Security, and National Health Commission issued a notice classifying methylphenidate as a second-class psychoactive drug, effective from October 1, 2023. Therefore, the "Shangtou e-cigarette" is a drug rather than a tobacco product. Potential users should be vigilant and avoid falling into the trap of drug abuse. If anyone is found selling or abusing it, please report to the police immediately while ensuring personal safety.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
